Search for Clinical Trial Results

Neurofibromatoses - 18 Studies Found
Status | Study |
Completed |
Study Name: Neurofibromatosis Type 1 Patient Registry Condition: Neurofibromatosis Type 1 Date: 2011-08-02 |
Completed |
Study Name: Modifying Genes in Neurofibromatosis 1 Condition: Neurofibromatosis 1 Date: 2012-05-29 Interventions: Other: No intervention No intervention |
Active, not recruiting |
Study Name: A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2009-02-23 Interventions:
|
Active, not recruiting |
Study Name: Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype Condition: Neurofibromatoses Date: 2015-02-25 Interventions:
|
Completed |
Study Name: Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) Condition: Neurofibromatosis 1 Date: 2006-07-13 Interventions:
|
Completed |
Study Name: Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2013-04-24 Interventions: Other: Neuropsychological examination and quality of life measures |
Completed |
Study Name: Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients Condition: Neurofibromatosis Type 1 Date: 2008-04-24 |
Suspended |
Study Name: PTC299 for Treatment of Neurofibromatosis Type 2 Condition: Neurofibromatosis 2 Date: 2009-05-28 Interventions: Drug: PTC299 PTC299 will be administered orally at 100 mg/dose twice per day for up to 1 year or until t |
Completed |
Study Name: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T Condition: Neurofibromatosis 1 Date: 2014-12-12 Interventions: Drug: Everolimus Everyone in the study will receive Everolimus at a starting dose of 10 mg daily and wil |
Completed |
Study Name: NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate Condition: Neurofibromatosis Type 1 Date: 2005-09-09 Interventions: Drug: methylphenidate |